FDA’s latest regulatory agenda adds proposed rules for pediatric study plans, container closure GMPs
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)Clinical TrialsGMPPediatric productsPharmaceuticalsRegulatory Intelligence/PolicyRegulatory strategySubmission and registrationUnited States